Tawa A - Search Results

1

Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group.

Tomizawa D, Tawa A, Watanabe T, Saito AM, Kudo K, Taga T, Iwamoto S, Shimada A, Terui K, Moritake H, Kinoshita A, Takahashi H, Nakayama H, Kiyokawa N, Isoyama K, Mizutani S, Hara J, Horibe K, Nakahata T, Adachi S. Tomizawa D, et al. Among authors: tawa a. Int J Hematol. 2013 Nov;98(5):578-88. doi: 10.1007/s12185-013-1429-2. Epub 2013 Sep 26. Int J Hematol. 2013. PMID: 24068655 Free PMC article.

2

Transient abnormal myelopoiesis in Down's syndrome.

Kurahashi H, Hara J, Yumura-Yagi K, Tawa A, Kawa-Ha K. Kurahashi H, et al. Among authors: tawa a. Leuk Lymphoma. 1992 Dec;8(6):465-75. doi: 10.3109/10428199209051029. Leuk Lymphoma. 1992. PMID: 1297480 Review.

3

In vivo and in vitro expression of myeloid antigens on B-lineage acute lymphoblastic leukemia cells.

Hara J, Kawa-Ha K, Yumura-Yagi K, Kurahashi H, Tawa A, Ishihara S, Inoue M, Murayama N, Okada S. Hara J, et al. Among authors: tawa a. Leukemia. 1991 Jan;5(1):19-25. Leukemia. 1991. PMID: 1705635

4

Clinical significance of CD7-positive stem cell leukemia. A distinct subtype of mixed lineage leukemia.

Yumura-Yagi K, Hara J, Kurahashi H, Okamura J, Koizumi S, Toyoda Y, Murayama N, Inoue M, Ishihara S, Tawa A, et al. Yumura-Yagi K, et al. Among authors: tawa a. Cancer. 1991 Nov 15;68(10):2273-80. doi: 10.1002/1097-0142(19911115)68:10<2273::aid-cncr2820681028>3.0.co;2-g. Cancer. 1991. PMID: 1717122

5

Poor prognosis of mediastinal non-Hodgkin's lymphoma with an immature phenotype of CD2+, CD7 (or CD5)+, CD3-, CD4-, and CD8-.

Yumura-Yagi K, Ishihara S, Hara J, Murata M, Izumi Y, Tawa A, Sato A, Matsumoto Y, Kozaiwa K, Nishida M, et al. Yumura-Yagi K, et al. Among authors: tawa a. Cancer. 1989 Feb 15;63(4):671-4. doi: 10.1002/1097-0142(19890215)63:4<671::aid-cncr2820630413>3.0.co;2-x. Cancer. 1989. PMID: 2783659

6

Molecular analysis of acute undifferentiated leukemia: two distinct subgroups at the DNA and RNA levels.

Hara J, Yumura-Yagi K, Tawa A, Ishihara S, Murata M, Terada N, Izumi Y, Champagne E, Takihara Y, Mak TW, et al. Hara J, et al. Among authors: tawa a. Blood. 1989 Oct;74(5):1738-46. Blood. 1989. PMID: 2790199 Free article.

7

[High-dose cytosine arabinoside therapy in children with non-Hodgkin's lymphoma--effective intensification and CNS prophylaxis].

Yumura K, Kawa K, Ishihara S, Hara J, Doi S, Murata M, Izumi Y, Tawa A, Yabuuchi H, Sato A, et al. Yumura K, et al. Among authors: tawa a. Rinsho Ketsueki. 1987 Mar;28(3):371-6. Rinsho Ketsueki. 1987. PMID: 3613124 Japanese. No abstract available.

8

[Successful chemotherapy for mediastinal seminoma--a case report].

Tawa A, Hara J, Yumura K, Doi S, Tomita K, Ikeda T, Sakurai M. Tawa A, et al. Gan To Kagaku Ryoho. 1984 Aug;11(8):1687-91. Gan To Kagaku Ryoho. 1984. PMID: 6476839 Japanese.

9

CD33+ B-cell precursor acute lymphoblastic leukemia in children: a distinct subgroup of B-cell precursor acute lymphoblastic leukemia.

Hara J, Hosoi G, Okamura T, Osugi Y, Ishihara S, Yumura-Yagi K, Kawa-Ha K, Tawa A. Hara J, et al. Among authors: tawa a. Int J Hematol. 1995 Feb;61(2):77-84. doi: 10.1016/0925-5710(94)00348-i. Int J Hematol. 1995. PMID: 7734715

10

Phenotypic characteristics of acute megakaryocytic leukemia and transient abnormal myelopoiesis.

Yumura-Yagi K, Hara J, Tawa A, Kawa-Ha K. Yumura-Yagi K, et al. Among authors: tawa a. Leuk Lymphoma. 1994 May;13(5-6):393-400. doi: 10.3109/10428199409049628. Leuk Lymphoma. 1994. PMID: 8069184 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page